These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16989407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 3. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K, Spellerberg M, Chapman P, Moller P, O'Donnell J.
    N Z Med J; 2004 Oct 08; 117(1203):U1097. PubMed ID: 15477921
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Topics on immunological tests for rheumatoid arthritis].
    Kumagai S, Nishimura K, Hayashi N.
    Rinsho Byori; 2004 Oct 08; 52(10):836-43. PubMed ID: 15624500
    [Abstract] [Full Text] [Related]

  • 7. [A new marker for the diagnosis of rheumatoid arthritis: cyclic citrullinated peptide antibodies (anti-CCP)].
    Altindiş M.
    Mikrobiyol Bul; 2003 Oct 08; 37(4):313-8. PubMed ID: 14748270
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [New biomarkers for rheumatoid arthritis].
    Hayashi N, Nishimura K, Kumagai S.
    Rinsho Byori; 2008 Apr 08; 56(4):297-308. PubMed ID: 18516964
    [Abstract] [Full Text] [Related]

  • 10. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
    Tedesco A, D'Agostino D, Soriente I, Amato P, Piccoli R, Sabatini P.
    Autoimmun Rev; 2009 Jan 08; 8(3):233-7. PubMed ID: 18708166
    [Abstract] [Full Text] [Related]

  • 11. [New diagnostic and evaluative tests for rheumatoid arthritis].
    Hayashi N, Nishimura K, Morinobu A, Kumagai S.
    Rinsho Byori; 2007 Apr 08; 55(4):388-96. PubMed ID: 17511271
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Vallbracht I, Helmke K.
    Autoimmun Rev; 2005 Jul 08; 4(6):389-94. PubMed ID: 16081030
    [Abstract] [Full Text] [Related]

  • 15. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr 08; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
    J Rheumatol; 2007 Aug 08; 34(8):1658-63. PubMed ID: 17611988
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.